false
Catalog
The Liver Meeting 2021
Hepatitis Debrief
Hepatitis Debrief
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Dr. Carla Brady from Duke University provided a summary of the recent research on viral hepatitis at the liver meeting. She highlighted key studies on hepatitis C, focusing on progress towards the global goal of elimination by 2030. Challenges in diagnosis, treatment, and care cascade were discussed, along with innovative approaches like rapid treatment initiation for vulnerable populations. The presentation also covered studies on hepatitis B, including a cascade of care analysis and the use of new therapies like ASC22 and VIR2218. Additionally, outcomes in pregnancy for hepatitis B and C, as well as hepatitis D testing and treatment, were addressed. The need for improved screening, management, and access to care for viral hepatitis patients was emphasized throughout the summary.
Keywords
viral hepatitis
Dr. Carla Brady
Duke University
research
hepatitis C
hepatitis B
×
Please select your language
1
English